Clinical Trial Update: Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole plus either goserelin or leuprolide in premenopausal women with estrogen receptor-positive stage IV breast cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Goserelin (Goserelin)
• Letrozole (letrozole)
• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: University of Washington | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED